Controlled Study to Evaluate the Safety and Efficacy of Azficel-T for Vocal Fold Scarring and Age-Related Dysphonia

NCT02120781 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Dysphonia Resulting From Vocal Fold Scarring
Age-related Dysphonia

Interventions

BIOLOGICAL: Azficel-T (autologous fibroblasts)
DRUG: Placebo

Sponsor

Castle Creek Biosciences, LLC.